Samuel Andrew Kerk

9PUBLICATIONS
37CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersElectrochemical energy storage and conversionSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 28, 2023
Spotlight on GOT2 in Cancer Metabolism.

Samuel A Kerk, Javier Garcia-Bermudez, Kivanc Birsoy

|Mar 07, 2023
Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.

Lingxin Zhu, Yi Tang, Xiao-Yan Li

|Feb 27, 2023
A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling.

Lingxin Zhu, Yi Tang, Xiao-Yan Li

|Nov 21, 2022
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells.

Christopher J Halbrook, Galloway Thurston, Seth Boyer

|Jul 11, 2022
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context.

Samuel A Kerk, Lin Lin, Amy L Myers

|Aug 12, 2021
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis.

Daniel M Kremer, Barbara S Nelson, Lin Lin

Pageof 2

Frequent Collaborators

7 joint publications

Costas Andreas Lyssiotis

3 joint publications

Yatrik M Shah

2 joint publications

Lingxin Zhu

2 joint publications

Andrew Charles Little